From Rockwell to Gotye, revisit the pop one-hit wonders that topped the charts once and never again — catchy hits, wild ...

Red light therapy shows promise in supporting everything from skin health to muscle-tissue repair—research suggests it may help boost collagen production, reduce inflammation, ease pain and soften ...

When he wasn’t playing with the groundbreaking dark-wave band Das Ich, he was a prominent figure in his country’s fight for ...

British rapper Sway DaSafo has died at 44. The news was announced in a Thursday, Sept. 17 Instagram post by the Music of Black Origin – or MOBO – Awards, which is an annual event celebrating Black ...

Add Yahoo as a preferred source to see more of our stories on Google. That being said, on September 19, 2006, one rapper released his first studio album, and it was celebrated by both critics and fans ...

Forbes contributors publish independent expert analyses and insights. Boaz Sobrado is a fintech leader and entrepreneur. Sep 17, 2026, 11:00pm EDT This voice experience is generated by AI. Learn more.

2006 was a great year in music, as some true classics were released. Gnarls Barkley came out with their debut album St. Elsewhere, Justin Timberlake dropped his mega sophomore hit album, ...

Chicago rapper Lil Durk has been found not guilty in a federal murder-for-hire trial. Prosecutors alleged that the Grammy winner conspired to murder a rival rapper, resulting in the shooting death of ...

One witness reportedly recalled hearing more than 100 shots fired BloodHound Q50/Instagram Rising Chicago rapper Bloodhound Q50, born Mikquale T. Cooper, was fatally shot while sitting in his Tesla ...

This content has been selected, created and edited by the Finextra editorial team based upon its relevance and interest to our community. The new digital asset custody solution will allow clients to ...

“Imported Grapes,” a new collaborative album from Denver-based hip-hop artists RO$$A¥ and Vitorio, began germinating three years ago out of opposition. The pair ...

Xenon Pharmaceuticals (XENE) fell 30% to reach its lowest level since November after the company paused enrollment in Phase 3 depression trials for its lead asset, azetukalner, following safety ...